Annual Retained Earnings
-$684.75 M
-$118.51 M-20.93%
31 December 2023
Summary:
Cara Therapeutics annual retained earnings is currently -$684.75 million, with the most recent change of -$118.51 million (-20.93%) on 31 December 2023. During the last 3 years, it has fallen by -$292.43 million (-74.54%). CARA annual retained earnings is now -1189.22% below its all-time high of -$53.11 million, reached on 31 December 2011.CARA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$747.93 M
-$12.48 M-1.70%
30 September 2024
Summary:
Cara Therapeutics quarterly retained earnings is currently -$747.93 million, with the most recent change of -$12.48 million (-1.70%) on 30 September 2024. Over the past year, it has dropped by -$95.53 million (-14.64%). CARA quarterly retained earnings is now -1159.49% below its all-time high of -$59.38 million, reached on 31 December 2012.CARA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -20.9% | -14.6% |
3 y3 years | -74.5% | -67.2% |
5 y5 years | -132.6% | -101.0% |
CARA Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -74.5% | at low | -67.2% | at low |
5 y | 5 years | -132.6% | at low | -101.0% | at low |
alltime | all time | -1189.2% | at low | -1159.5% | at low |
Cara Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$747.93 M(+1.7%) |
June 2024 | - | -$735.46 M(+2.8%) |
Mar 2024 | - | -$715.44 M(+4.5%) |
Dec 2023 | -$684.75 M(+20.9%) | -$684.75 M(+5.0%) |
Sept 2023 | - | -$652.41 M(+4.5%) |
June 2023 | - | -$624.38 M(+5.3%) |
Mar 2023 | - | -$592.90 M(+4.7%) |
Dec 2022 | -$566.23 M(+17.8%) | -$566.23 M(+5.7%) |
Sept 2022 | - | -$535.89 M(+4.5%) |
June 2022 | - | -$512.71 M(+0.8%) |
Mar 2022 | - | -$508.51 M(+5.8%) |
Dec 2021 | -$480.76 M(+22.5%) | -$480.76 M(+7.5%) |
Sept 2021 | - | -$447.38 M(+0.2%) |
June 2021 | - | -$446.36 M(+7.4%) |
Mar 2021 | - | -$415.62 M(+5.9%) |
Dec 2020 | -$392.32 M(-2.1%) | -$392.32 M(-16.7%) |
Sept 2020 | - | -$471.23 M(+3.6%) |
June 2020 | - | -$454.72 M(+5.8%) |
Mar 2020 | - | -$429.65 M(+7.2%) |
Dec 2019 | -$400.73 M(+36.1%) | -$400.73 M(+7.7%) |
Sept 2019 | - | -$372.12 M(+9.7%) |
June 2019 | - | -$339.27 M(+7.3%) |
Mar 2019 | - | -$316.31 M(+7.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | -$294.35 M(+33.6%) | -$294.35 M(+7.5%) |
Sept 2018 | - | -$273.70 M(+7.6%) |
June 2018 | - | -$254.30 M(+7.3%) |
Mar 2018 | - | -$237.11 M(+7.6%) |
Dec 2017 | -$220.34 M(+35.9%) | -$220.34 M(+6.9%) |
Sept 2017 | - | -$206.16 M(+6.4%) |
June 2017 | - | -$193.72 M(+5.0%) |
Mar 2017 | - | -$184.42 M(+13.7%) |
Dec 2016 | -$162.17 M(+54.6%) | -$162.17 M(+15.7%) |
Sept 2016 | - | -$140.20 M(+9.0%) |
June 2016 | - | -$128.66 M(+11.3%) |
Mar 2016 | - | -$115.58 M(+10.2%) |
Dec 2015 | -$104.89 M(+30.8%) | -$104.89 M(+10.0%) |
Sept 2015 | - | -$95.36 M(+5.3%) |
June 2015 | - | -$90.57 M(+6.7%) |
Mar 2015 | - | -$84.89 M(+5.8%) |
Dec 2014 | -$80.20 M(+28.4%) | -$80.20 M(+5.5%) |
Sept 2014 | - | -$76.03 M(+9.4%) |
June 2014 | - | -$69.48 M(+5.5%) |
Mar 2014 | - | -$65.84 M(+5.4%) |
Dec 2013 | -$62.46 M(+5.2%) | -$62.46 M(+3.5%) |
Sept 2013 | - | -$60.36 M(+1.6%) |
Dec 2012 | -$59.38 M(+11.8%) | -$59.38 M |
Dec 2011 | -$53.11 M | - |
FAQ
- What is Cara Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Cara Therapeutics?
- What is Cara Therapeutics annual retained earnings year-on-year change?
- What is Cara Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cara Therapeutics?
- What is Cara Therapeutics quarterly retained earnings year-on-year change?
What is Cara Therapeutics annual retained earnings?
The current annual retained earnings of CARA is -$684.75 M
What is the all time high annual retained earnings for Cara Therapeutics?
Cara Therapeutics all-time high annual retained earnings is -$53.11 M
What is Cara Therapeutics annual retained earnings year-on-year change?
Over the past year, CARA annual retained earnings has changed by -$118.51 M (-20.93%)
What is Cara Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CARA is -$747.93 M
What is the all time high quarterly retained earnings for Cara Therapeutics?
Cara Therapeutics all-time high quarterly retained earnings is -$59.38 M
What is Cara Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CARA quarterly retained earnings has changed by -$95.53 M (-14.64%)